Vocera Receives Elite Australian Certification from One of the Toughest Regulatory Agencies in the World
SAN JOSE, Calif. - December 8, 2014 - Vocera Communications, Inc. (NYSE: VCRA), the leading provider of integrated, intelligent communication solutions for mission-critical mobile environments, today announced that the Vocera Cardiac Consult solution has been granted certification by Australia's Therapeutic Goods Administration (TGA).
The TGA is Australia's government agency for regulating medical devices and drugs, and is considered one of the toughest regulatory agencies in the world.
"This elite certification validates the clinical relevance of our cardiac consult solution, and provides healthcare providers in Australia with a powerful remote diagnostic tool that delivers critical information and cardiology expertise to remote care points," said Gautam M Shah, vice president of product management, Vocera. "Our innovative communication solution will empower cardiologists and care teams across Australia, and I believe will ultimately save lives."
Vocera Cardiac Consult is a powerful, remote diagnostic tool that delivers 12-lead ECGs to physicians' smartphones and tablets over any available data network. This solution allows physicians to perform measurements and compare current to historic ECGs, enabling immediate diagnosis and response to improve patient safety and cardiology coverage, reduce false cardiac catheterization lab activation costs, and improve door-to-balloon times.
Vocera empowers integrated, intelligent communication in healthcare, hospitality, energy and other mission-critical mobile environments. Widely recognized for developing smarter ways to instantly communicate and collaborate, Vocera offers a comprehensive portfolio of solutions that improve efficiency throughout organizations. The Vocera Communication System is installed in more than 1,200 organizations worldwide. The Vocera portfolio improves workflow, quality, safety and outcomes while elevating the customer and patient experience. In addition to providing innovative technology, Vocera drives thought leadership and new standards to improve patient experience via its research collaborative, the Experience Innovation Network. Vocera is headquartered in San Jose, Calif., with offices in San Francisco, Tennessee, Canada, India, United Arab Emirates, and the United Kingdom. For more information, visit www.vocera.com and @VoceraComm on Twitter.
The Vocera logo is a trademark of Vocera Communications, Inc. Vocera® is a trademark of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.
Vocera technology has bridged our communication gaps – allowing instant hands-free voice calls, improving patient care coordination, and enhancing staff and patient safety by reducing response times.Norman Bowman, Clinical Ward Administrator at Gateshead Health NHS Foundation Trust
The Vocera numbers speak for themselves, and they show this technology can dramatically reduce the time it takes to connect with a colleague and get a response. That has a real impact on the care we provide.Adrian Plunkett, Paediatric Intensivist Consultant at Birmingham Women’s and Children’s Hospital
Vocera Badges allow our team to safely communicate under PPE during this COVID-19 pandemic.Victoria Sudron, Service Improvement Coordinator at North Tees and Hartlepool NHS Trust
Since implementing Vocera, we no longer have communication delays due to the ‘page and wait’ scenario.Nick Roper, Clinical Director at North Tees & Hartlepool NHS Trust
Vocera empowers people in mission-critical environments to instantly connect via secure, mobile, integrated and intelligent communication solutions.